Advertisement
Screener

ClearPoint Neuro, Inc. (CLPT) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

ClearPoint Neuro, Inc. Research and Development Expense

ClearPoint Neuro, Inc. (CLPT) reported Research and Development Expense of $4.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-03

  • ClearPoint Neuro, Inc. research and development expense for the quarter ending 2026-06-30 was $4.63M, a 20.97% increase year-over-year.
  • ClearPoint Neuro, Inc. research and development expense for the quarter ending 2026-03-31 was $4.52M, a 33.83% increase year-over-year.
  • ClearPoint Neuro, Inc. research and development expense for the quarter ending 2025-12-31 was $3.24M, a 2.85% decline year-over-year.
  • ClearPoint Neuro, Inc. research and development expense for the quarter ending 2025-09-30 was $3.45M, a 4.13% increase year-over-year.
  • ClearPoint Neuro, Inc. research and development expense for fiscal 2025 was $13.90M, a 12.14% increase from fiscal 2024.
  • ClearPoint Neuro, Inc. research and development expense for fiscal 2024 was $12.39M, a 5.83% increase from fiscal 2023.
  • ClearPoint Neuro, Inc. research and development expense for fiscal 2023 was $11.71M, a 7.48% increase from fiscal 2022.
  • ClearPoint Neuro, Inc. research and development expense for fiscal 2022 was $10.89M, a 17.38% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2026-06-30$4.63M
10-Q · filed 2026-08-03
$9.15M
10-Q · filed 2026-08-03
$12.39M
derived: sum of 3 quarters · filed 2026-08-03
$15.84M
derived: sum of 4 quarters · filed 2026-08-03
2026-03-31$4.52M
10-Q · filed 2026-05-13
$7.76M
derived: sum of 2 quarters · filed 2026-05-13
$11.21M
derived: sum of 3 quarters · filed 2026-05-13
$15.04M
derived: sum of 4 quarters · filed 2026-08-03
2025-12-31$3.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17
$6.69M
derived: sum of 2 quarters · filed 2026-03-17
$10.52M
derived: sum of 3 quarters · filed 2026-08-03
$13.90M
10-K · filed 2026-03-17
2025-09-30$3.45M
10-Q · filed 2025-11-06
$7.28M
derived: sum of 2 quarters · filed 2026-08-03
$10.66M
10-Q · filed 2025-11-06
$13.99M
derived: sum of 4 quarters · filed 2026-08-03
2025-06-30$3.83M
10-Q · filed 2026-08-03
$7.21M
10-Q · filed 2026-08-03
$10.54M
derived: sum of 3 quarters · filed 2026-08-03
$13.86M
derived: sum of 4 quarters · filed 2026-08-03
2025-03-31$3.38M
10-Q · filed 2026-05-13
$6.71M
derived: sum of 2 quarters · filed 2026-05-13
$10.03M
derived: sum of 3 quarters · filed 2026-05-13
$13.15M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$3.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17
$6.65M
derived: sum of 2 quarters · filed 2026-03-17
$9.77M
derived: sum of 3 quarters · filed 2026-03-17
$12.39M
10-K · filed 2026-03-17
2024-09-30$3.31M
10-Q · filed 2025-11-06
$6.43M
derived: sum of 2 quarters · filed 2025-11-06
$9.06M
10-Q · filed 2025-11-06
$11.71M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$3.12M
10-Q · filed 2025-08-12
$5.75M
10-Q · filed 2025-08-12
$8.40M
derived: sum of 3 quarters · filed 2025-08-12
$10.83M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$2.63M
10-Q · filed 2025-05-13
$5.28M
derived: sum of 2 quarters · filed 2025-05-13
$7.71M
derived: sum of 3 quarters · filed 2025-05-13
$11.31M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$2.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$5.08M
derived: sum of 2 quarters · filed 2025-02-26
$8.69M
derived: sum of 3 quarters · filed 2025-02-26
$11.71M
10-K · filed 2025-02-26
2023-09-30$2.43M
10-Q · filed 2024-11-07
$6.03M
derived: sum of 2 quarters · filed 2024-11-07
$9.06M
10-Q · filed 2024-11-07
$11.98M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$3.60M
10-Q · filed 2024-08-07
$6.63M
10-Q · filed 2024-08-07
$9.55M
derived: sum of 3 quarters · filed 2024-08-07
$12.21M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31$3.02M
10-Q · filed 2024-05-07
$5.95M
derived: sum of 2 quarters · filed 2024-05-07
$8.60M
derived: sum of 3 quarters · filed 2024-05-07
$11.02M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31$2.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
$5.58M
derived: sum of 2 quarters · filed 2024-03-12
$7.99M
derived: sum of 3 quarters · filed 2024-03-12
$10.89M
10-K · filed 2024-03-12
2022-09-30$2.65M
10-Q · filed 2023-11-09
$2.45M
10-Q · filed 2022-11-08
$5.07M
derived: sum of 2 quarters · filed 2023-11-09
$7.97M
10-Q · filed 2023-11-09
$7.27M
10-Q · filed 2022-11-08
$11.04M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$2.41M
10-Q · filed 2023-08-08
$2.28M
10-Q · filed 2022-08-10
$5.31M
10-Q · filed 2023-08-08
$4.82M
10-Q · filed 2022-08-10
$8.38M
derived: sum of 3 quarters · filed 2023-08-08
$10.99M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$2.90M
10-Q · filed 2023-05-11
$2.53M
10-Q · filed 2022-05-11
$5.97M
derived: sum of 2 quarters · filed 2023-05-11
$8.57M
derived: sum of 3 quarters · filed 2023-05-11
$10.68M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$3.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$5.67M
derived: sum of 2 quarters · filed 2023-03-01
$7.78M
derived: sum of 3 quarters · filed 2023-03-01
$9.28M
10-K · filed 2023-03-01
$8.98M
10-K · filed 2022-03-09
2021-09-30$2.60M
10-Q · filed 2022-11-08
$2.63M
10-Q · filed 2021-11-10
$4.71M
derived: sum of 2 quarters · filed 2022-11-08
$6.21M
10-Q · filed 2022-11-08
$6.25M
10-Q · filed 2021-11-10
$8.19M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$2.11M
10-Q · filed 2022-08-10
$2.12M
10-Q · filed 2021-08-12
$3.67M
10-Q · filed 2022-08-10
$3.69M
10-Q · filed 2021-08-12
$5.58M
derived: sum of 3 quarters · filed 2022-08-10
$6.73M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$1.56M
10-Q · filed 2022-05-11
$3.48M
derived: sum of 2 quarters · filed 2022-05-11
$4.62M
derived: sum of 3 quarters · filed 2022-05-11
$5.43M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31$1.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09
$3.06M
derived: sum of 2 quarters · filed 2022-03-09
$3.87M
derived: sum of 3 quarters · filed 2022-03-09
$4.69M
10-K · filed 2022-03-09
2020-09-30$1.14M
10-Q · filed 2021-11-10
$1.21M
10-Q · filed 2020-11-12
$1.96M
derived: sum of 2 quarters · filed 2021-11-10
$2.77M
10-Q · filed 2021-11-10
$2.86M
10-Q · filed 2020-11-12
$3.54M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$812.00K
10-Q · filed 2021-08-12
$822.30K
10-Q · filed 2020-08-13
$1.63M
10-Q · filed 2021-08-12
$1.65M
10-Q · filed 2020-08-13
$2.40M
derived: sum of 3 quarters · filed 2021-08-12
$3.16M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$818.00K
10-Q · filed 2021-05-11
$829.53K
10-Q · filed 2020-05-13
$1.58M
derived: sum of 2 quarters · filed 2021-05-11
$2.35M
derived: sum of 3 quarters · filed 2021-05-11
$3.04M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31$765.78K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
$1.53M
derived: sum of 2 quarters · filed 2021-03-22
$2.23M
derived: sum of 3 quarters · filed 2021-03-22
$2.81M
10-K · filed 2021-03-22
$2.92M
10-K · filed 2020-03-27
2019-09-30$761.88K
10-Q · filed 2020-11-12
$1.46M
derived: sum of 2 quarters · filed 2020-11-12
$2.04M
10-Q · filed 2020-11-12
$2.53M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$697.80K
10-Q · filed 2020-08-13
$1.28M
10-Q · filed 2020-08-13
$1.76M
derived: sum of 3 quarters · filed 2020-08-13
$2.38M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$584.54K
10-Q · filed 2020-05-13
$1.07M
derived: sum of 2 quarters · filed 2020-05-13
$1.68M
derived: sum of 3 quarters · filed 2020-05-13
$2.35M
derived: sum of 4 quarters · filed 2020-05-13
2018-12-31$481.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
$1.10M
derived: sum of 2 quarters · filed 2020-03-27
$1.76M
derived: sum of 3 quarters · filed 2020-03-27
$2.31M
10-K · filed 2020-03-27
2018-09-30$617.24K
10-Q · filed 2019-11-13
$1.28M
derived: sum of 2 quarters · filed 2019-11-13
$1.83M
10-Q · filed 2019-11-13
$2.41M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30$665.31K
10-Q · filed 2019-08-12
$1.21M
10-Q · filed 2019-08-12
$1.79M
derived: sum of 3 quarters · filed 2019-08-12
$2.38M
derived: sum of 4 quarters · filed 2019-08-12
2018-03-31$546.33K
10-Q · filed 2019-05-13
$1.13M
derived: sum of 2 quarters · filed 2019-05-13
$1.72M
derived: sum of 3 quarters · filed 2019-05-13
$2.80M
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31$582.12K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$1.17M
derived: sum of 2 quarters · filed 2019-04-01
$2.26M
derived: sum of 3 quarters · filed 2019-04-01
$2.81M
10-K · filed 2019-04-01
2017-09-30$589.72K
10-Q · filed 2018-11-13
$1.67M
derived: sum of 2 quarters · filed 2018-11-13
$2.23M
10-Q · filed 2018-11-13
$2.76M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$1.08M
10-Q · filed 2018-08-14
$1.64M
10-Q · filed 2018-08-14
$2.17M
derived: sum of 3 quarters · filed 2018-08-14
$2.86M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$557.70K
10-Q · filed 2018-05-15
$1.09M
derived: sum of 2 quarters · filed 2018-05-15
$1.78M
derived: sum of 3 quarters · filed 2018-05-15
$2.53M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$529.71K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21
$1.22M
derived: sum of 2 quarters · filed 2018-03-21
$1.97M
derived: sum of 3 quarters · filed 2018-03-21
$2.63M
10-K · filed 2018-03-21
2016-09-30$691.33K
10-Q · filed 2017-11-06
$1.44M
derived: sum of 2 quarters · filed 2017-11-06
$2.10M
10-Q · filed 2017-11-06
$2.62M
derived: sum of 4 quarters · filed 2017-11-06
2016-06-30$749.94K
10-Q · filed 2017-08-11
$1.41M
10-Q · filed 2017-08-11
$1.93M
derived: sum of 3 quarters · filed 2017-08-11
$2.41M
derived: sum of 4 quarters · filed 2017-08-11
2016-03-31$657.19K
10-Q · filed 2017-05-09
$1.18M
derived: sum of 2 quarters · filed 2017-05-09
$1.66M
derived: sum of 3 quarters · filed 2017-05-09
$2.09M
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31$522.61K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$1.00M
derived: sum of 2 quarters · filed 2017-03-09
$1.43M
derived: sum of 3 quarters · filed 2017-03-09
$1.96M
10-K · filed 2017-03-09
2015-09-30$480.28K
10-Q · filed 2016-11-09
$907.21K
derived: sum of 2 quarters · filed 2016-11-09
$1.43M
10-Q · filed 2016-11-09
$2.14M
derived: sum of 4 quarters · filed 2016-11-09
2015-06-30$426.93K
10-Q/A · filed 2016-09-21
$954.44K
10-Q/A · filed 2016-09-21
$1.66M
derived: sum of 3 quarters · filed 2016-09-21
$2.54M
derived: sum of 4 quarters · filed 2016-09-21
2015-03-31$527.51K
10-Q · filed 2016-05-06
$1.24M
derived: sum of 2 quarters · filed 2016-05-06
$2.11M
derived: sum of 3 quarters · filed 2016-05-06
$3.01M
derived: sum of 4 quarters · filed 2016-05-06
2014-12-31$707.70K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
$1.58M
derived: sum of 2 quarters · filed 2016-03-25
$2.48M
derived: sum of 3 quarters · filed 2016-03-25
$3.30M
10-K · filed 2016-03-25
2014-09-30$873.37K
10-Q · filed 2015-11-13
$1.77M
derived: sum of 2 quarters · filed 2015-11-13
$2.59M
10-Q · filed 2015-11-13
$3.27M
derived: sum of 4 quarters · filed 2015-11-13
2014-06-30$898.42K
10-Q · filed 2015-08-10
$1.72M
10-Q · filed 2015-08-10
$2.40M
derived: sum of 3 quarters · filed 2015-08-10
$3.13M
derived: sum of 4 quarters · filed 2015-08-10
2014-03-31$817.62K
10-Q · filed 2015-05-07
$1.50M
derived: sum of 2 quarters · filed 2015-05-07
$2.23M
derived: sum of 3 quarters · filed 2015-05-07
$2.97M
derived: sum of 4 quarters · filed 2015-05-07
2013-12-31$684.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17
$1.41M
derived: sum of 2 quarters · filed 2015-03-17
$2.15M
derived: sum of 3 quarters · filed 2015-03-17
$2.92M
10-K · filed 2015-03-17
2013-09-30$725.30K
10-Q · filed 2014-11-14
$1.47M
derived: sum of 2 quarters · filed 2014-11-14
$2.24M
10-Q · filed 2014-11-14
$317.42K
10-Q · filed 2012-11-14
2013-06-30$741.82K
10-Q · filed 2014-08-11
$1.51M
10-Q · filed 2014-08-11
$2.25M
derived: sum of 3 quarters · filed 2014-08-11
$2.82M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$771.45K
10-Q · filed 2014-05-13
$1.51M
derived: sum of 2 quarters · filed 2014-05-13
$2.08M
derived: sum of 3 quarters · filed 2014-05-13
$2.57M
derived: sum of 4 quarters · filed 2014-05-13
2012-12-31$735.25K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
$1.31M
derived: sum of 2 quarters · filed 2014-03-28
$1.79M
derived: sum of 3 quarters · filed 2014-03-28
$2.48M
10-K · filed 2014-03-28
2012-09-30$573.56K
10-Q · filed 2013-11-13
$1.06M
derived: sum of 2 quarters · filed 2013-11-13
$1.75M
10-Q · filed 2013-11-13
$2.87M
derived: sum of 4 quarters · filed 2013-11-13
2012-06-30$486.02K
10-Q · filed 2013-08-14
$1.18M
10-Q · filed 2013-08-14
$2.29M
derived: sum of 3 quarters · filed 2013-08-19
$3.20M
derived: sum of 4 quarters · filed 2013-08-19
2012-03-31$689.67K
10-Q/A · filed 2013-08-19
$1.81M
derived: sum of 2 quarters · filed 2013-08-19
$2.72M
derived: sum of 3 quarters · filed 2013-08-19
$3.78M
derived: sum of 4 quarters · filed 2013-08-19
2011-12-31$1.12M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-19
$2.03M
derived: sum of 2 quarters · filed 2013-08-19
$3.09M
derived: sum of 3 quarters · filed 2013-08-19
$4.25M
10-K/A · filed 2013-08-19
2011-09-30$909.91K
10-Q · filed 2012-11-14
$1.97M
derived: sum of 2 quarters · filed 2012-11-14
$3.13M
10-Q · filed 2012-11-14
2011-06-30$1.06M
10-Q · filed 2012-08-14
$2.22M
10-Q · filed 2012-08-14
2011-03-31$1.17M
10-Q/A · filed 2012-06-07
2010-12-31$5.68M
10-K/A · filed 2013-08-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
NeuroPace Inc (NPCE)United States$0.480B-28.52
CARLSMED, INC. (CARL)United States$0.405B
Orthofix Medical Inc. (OFIX)$0.373B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Embecta Corp. (EMBC)United States$0.319B2.10